GlassScriptPhysician profile
Braden J Moore
NPI 1730475419
$5,142.79
in general payments reported to CMS, 2019-2025
29 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $237 · 2021: $1,232 · 2022: $816 · 2023: $51.16 · 2024: $742 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116 · Travel and Lodging: $879 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.63 |
| Travel and Lodging | $879.12 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,812.50 | 2019-2025 | |
| Pacira Therapeutics, INC. | $539.21 | 2019-2021 | |
| Stryker Corporation | $495.08 | 2019-2024 | Augment Injectable |
| Orthofix Medical, INC. | $493.37 | 2020-2024 | Truelok |
| Pylant Medical | $361.72 | 2022-2025 | |
| Smith+Nephew, INC. | $310.82 | 2019-2024 | Grafix Pl, Renasys Touch |
| Globus Medical, INC. | $176.51 | 2021-2022 | |
| Abbvie INC. | $133.82 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $112.48 | 2019-2021 | |
| Intuitive Surgical, INC. | $100.00 | 2025 | |
| Radius Health, INC. | $91.29 | 2019-2021 | |
| Abbott Laboratories | $88.45 | 2020-2025 | Proclaim, Ionicrf |
| Bioventus LLC | $71.55 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $46.29 | 2021-2022 | |
| Ethicon US, LLC | $37.72 | 2023 | Stratafix, Surgiflo Hemostatic Matrix, Dermabond Prineo |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $29.89 | 2021 | |
| Horizon Therapeutics Plc | $29.28 | 2019 | |
| Amgen INC. | $26.39 | 2019 | |
| Acell, INC. | $24.24 | 2020 | |
| Baxter Healthcare | $21.60 | 2022 | |
| Zimmer Biomet Holdings, INC. | $20.46 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.62 | 2025 | Exparel |
| Organogenesis INC. | $18.18 | 2024 | |
| Wright Medical Technology, INC. | $17.99 | 2019 | |
| Pfizer INC. | $14.52 | 2019 | |
| Medtronic, INC. | $13.44 | 2023 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $12.94 | 2019 | |
| Osiris Therapeutics INC. | $12.19 | 2019 | |
| Vericel Corporation | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Braden Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.